{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:24:28Z","timestamp":1793996668314,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012403","name":"Texas Biomedical Research Institute","doi-asserted-by":"publisher","award":["Douglass Graduate Fellowship"],"award-info":[{"award-number":["Douglass Graduate Fellowship"]}],"id":[{"id":"10.13039\/100012403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012394","name":"Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI-146340"],"award-info":[{"award-number":["R01 AI-146340"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81457-0","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T01:58:58Z","timestamp":1735351138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection outcomes in human macrophages"],"prefix":"10.1038","volume":"14","author":[{"given":"Alyssa","family":"Schami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Nurul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amberlee","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reagan","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Kreiswirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barun","family":"Mathema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Belisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi B.","family":"Torrelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"81457_CR1","unstructured":"(WHO) WHO. WHO Tuberculosis Fact Sheet 2023 - https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. WHO, 2023."},{"key":"81457_CR2","unstructured":"WHO. Global Tuberculosis Report. 2023. Geneva: World Health Organization."},{"key":"81457_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1274175","author":"A Schami","year":"2023","unstructured":"Schami, A. et al. Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host. Front. Cell Infect. Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2023.1274175 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"81457_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02909","author":"A Garcia-Vilanova","year":"2019","unstructured":"Garcia-Vilanova, A., Chan, J. & Torrelles, J. B. Underestimated manipulative roles of mycobacterium tuberculosis cell envelope glycolipids during infection. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.02909 (2019).","journal-title":"Front. Immunol."},{"key":"81457_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021105","author":"M Jackson","year":"2014","unstructured":"Jackson, M. The mycobacterial cell envelope-lipids. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a021105 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"81457_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2005.07.001","author":"KC Onwueme","year":"2005","unstructured":"Onwueme, K. C. et al. The dimycocerosate ester polyketide virulence factors of mycobacteria. Prog. Lipid Res. https:\/\/doi.org\/10.1016\/j.plipres.2005.07.001 (2005).","journal-title":"Prog. Lipid Res."},{"key":"81457_CR7","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.000440","author":"S Samanta","year":"2017","unstructured":"Samanta, S. et al. Mycobacterial phenolic glycolipid synthesis is regulated by cAMP-dependent lysine acylation of FadD22. Microbiology (Reading) https:\/\/doi.org\/10.1099\/mic.0.000440 (2017).","journal-title":"Microbiology (Reading)"},{"key":"81457_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0245-0","author":"NC Howard","year":"2018","unstructured":"Howard, N. C. et al. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-018-0245-0 (2018).","journal-title":"Nat. Microbiol."},{"key":"81457_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1462-5822.2004.00368.x","volume":"6","author":"C Rousseau","year":"2004","unstructured":"Rousseau, C. et al. Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cell Microbiol. 6, 277\u2013287 (2004).","journal-title":"Cell Microbiol."},{"key":"81457_CR10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100662200","author":"LR Camacho","year":"2001","unstructured":"Camacho, L. R. et al. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M100662200 (2001).","journal-title":"J. Biol. Chem."},{"key":"81457_CR11","doi-asserted-by":"publisher","first-page":"24616","DOI":"10.1074\/jbc.M111.247601","volume":"286","author":"SS Chavadi","year":"2011","unstructured":"Chavadi, S. S. et al. Inactivation of tesA reduces cell wall lipid production and increases drug susceptibility in mycobacteria. J. Biol. Chem. 286, 24616\u201324625 (2011).","journal-title":"J. Biol. Chem."},{"key":"81457_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnw016","author":"P Mohandas","year":"2016","unstructured":"Mohandas, P. et al. Pleiotropic consequences of gene knockouts in the phthiocerol dimycocerosate and phenolic glycolipid biosynthetic gene cluster of the opportunistic human pathogen Mycobacterium marinum. Fems Microbiol. Lett. https:\/\/doi.org\/10.1093\/femsle\/fnw016 (2016).","journal-title":"Fems Microbiol. Lett."},{"key":"81457_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/aac.04856-14","author":"K Soetaert","year":"2015","unstructured":"Soetaert, K. et al. Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/aac.04856-14 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"81457_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01013-12","author":"GP Bisson","year":"2012","unstructured":"Bisson, G. P. et al. Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis. J. Bacteriol. https:\/\/doi.org\/10.1128\/JB.01013-12 (2012).","journal-title":"J. Bacteriol."},{"key":"81457_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41564-018-0245-0","volume":"3","author":"NC Howard","year":"2018","unstructured":"Howard, N. C. et al. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes. Nat. Microbiol. 3, 1099\u20131108 (2018).","journal-title":"Nat. Microbiol."},{"key":"81457_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tube.2010.02.003","volume":"90","author":"JB Torrelles","year":"2010","unstructured":"Torrelles, J. B. & Schlesinger, L. S. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis 90, 84\u201393 (2010).","journal-title":"Tuberculosis"},{"key":"81457_CR17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.2.541","author":"PF Barnes","year":"1992","unstructured":"Barnes, P. F. et al. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan relationship to chemical structure. J. Immunol. https:\/\/doi.org\/10.4049\/jimmunol.149.2.541 (1992).","journal-title":"J. Immunol."},{"key":"81457_CR18","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1128\/IAI.69.4.2001-2010.2001","volume":"69","author":"ED Chan","year":"2001","unstructured":"Chan, E. D. et al. Induction of inducible nitric oxide synthase-NO\u2022 by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kB signaling pathways. Infect. Immun. 69, 2001\u20132010 (2001).","journal-title":"Infect. Immun."},{"key":"81457_CR19","doi-asserted-by":"publisher","first-page":"34896","DOI":"10.1074\/jbc.M103908200","volume":"276","author":"M Gilleron","year":"2001","unstructured":"Gilleron, M. et al. Acylation state of the phosphatidylinositol mannosides from Mycobcterium bovus bacillus calmette guerin and ability to induce granuloma and recruit natural killer T cells. J. Biol. Chem. 276, 34896\u201334904 (2001).","journal-title":"J. Biol. Chem."},{"key":"81457_CR20","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1073\/pnas.0737613100","volume":"100","author":"RA Fratti","year":"2003","unstructured":"Fratti, R. A. et al. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. U. S. A. 100, 5437\u20135442. https:\/\/doi.org\/10.1073\/pnas.0737613100 (2003).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"81457_CR21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051239","author":"PB Kang","year":"2005","unstructured":"Kang, P. B. et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20051239 (2005).","journal-title":"J. Exp. Med."},{"key":"81457_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/fty026","author":"J Turner","year":"2018","unstructured":"Turner, J. & Torrelles, J. B. Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis. Pathog. Dis. https:\/\/doi.org\/10.1093\/femspd\/fty026 (2018).","journal-title":"Pathog. Dis."},{"key":"81457_CR23","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1074\/jbc.M004010200","volume":"276","author":"K-H Khoo","year":"2001","unstructured":"Khoo, K.-H., Tang, J.-B. & Chatterjee, D. Variation in mannose-capped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex. J. Biol. Chem. 276, 3863\u20133871. https:\/\/doi.org\/10.1074\/jbc.M004010200 (2001).","journal-title":"J. Biol. Chem."},{"key":"81457_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cws078","author":"JB Torrelles","year":"2012","unstructured":"Torrelles, J. B. et al. Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells. Glycobiology https:\/\/doi.org\/10.1093\/glycob\/cws078 (2012).","journal-title":"Glycobiology"},{"key":"81457_CR25","doi-asserted-by":"publisher","first-page":"31417","DOI":"10.1074\/jbc.M806350200","volume":"283","author":"JB Torrelles","year":"2008","unstructured":"Torrelles, J. B. et al. Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. J. Biol. Chem. 283, 31417\u201331428 (2008).","journal-title":"J. Biol. Chem."},{"key":"81457_CR26","doi-asserted-by":"publisher","first-page":"41227","DOI":"10.1074\/jbc.M405180200","volume":"279","author":"JB Torrelles","year":"2004","unstructured":"Torrelles, J. B. et al. Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis. J. Biol. Chem. 279, 41227\u201341239 (2004).","journal-title":"J. Biol. Chem."},{"key":"81457_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02763-21","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Arabinosyltransferase C mediates multiple drugs intrinsic resistance by altering cell envelope permeability in mycobacterium abscessus. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/spectrum.02763-21 (2022).","journal-title":"Microbiol. Spectr."},{"key":"81457_CR28","doi-asserted-by":"publisher","DOI":"10.2147\/idr.S346869","author":"M Yimcharoen","year":"2022","unstructured":"Yimcharoen, M. et al. The regulation of ManLAM-related gene expression in mycobacterium tuberculosis with different drug resistance Profiles following isoniazid treatment. Infect. Drug Resist. https:\/\/doi.org\/10.2147\/idr.S346869 (2022).","journal-title":"Infect. Drug Resist."},{"key":"81457_CR29","doi-asserted-by":"publisher","first-page":"28682","DOI":"10.1074\/jbc.271.45.28682","volume":"271","author":"KH Khoo","year":"1996","unstructured":"Khoo, K. H. et al. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis - Inhibition of arabinan biosynthesis by ethambutol. J. Biol. Chem. 271, 28682\u201328690 (1996).","journal-title":"J. Biol. Chem."},{"key":"81457_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcsw.2020.100044","author":"SM Batt","year":"2020","unstructured":"Batt, S. M. et al. Antibiotics and resistance the two-sided coin of the mycobacterial cell wall. Cell Surface (Amsterdam, Netherlands) https:\/\/doi.org\/10.1016\/j.tcsw.2020.100044 (2020).","journal-title":"Cell Surface (Amsterdam, Netherlands)"},{"key":"81457_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.10.006","author":"AA Velayati","year":"2018","unstructured":"Velayati, A. A., Farnia, P. & Hoffner, S. Drug-resistant Mycobacterium tuberculosis: Epidemiology and role of morphological alterations. J. Glob. Antimicrob. Resist. https:\/\/doi.org\/10.1016\/j.jgar.2017.10.006 (2018).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"81457_CR32","first-page":"193","volume":"4","author":"AA Velayati","year":"2011","unstructured":"Velayati, A. A. et al. Sequential adaptation in latent tuberculosis bacilli: observation by atomic force microscopy (AFM). Int. J. Clin. Exp. Med. 4, 193\u2013199 (2011).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"81457_CR33","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1183\/09031936.00064510","volume":"36","author":"AA Velayati","year":"2010","unstructured":"Velayati, A. A. et al. New insight into extremely drug-resistant tuberculosis: using atomic force microscopy. Eur. Respir. J. 36, 1490\u20131493. https:\/\/doi.org\/10.1183\/09031936.00064510 (2010).","journal-title":"Eur. Respir. J."},{"key":"81457_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000226425","volume":"55","author":"AA Velayati","year":"2009","unstructured":"Velayati, A. A. et al. Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: using transmission electron microscopy. Chemotherapy 55, 303\u2013307. https:\/\/doi.org\/10.1159\/000226425 (2009).","journal-title":"Chemotherapy"},{"key":"81457_CR35","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00081909","author":"AA Velayati","year":"2009","unstructured":"Velayati, A. A. et al. Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level. Eur. Respir. J. https:\/\/doi.org\/10.1183\/09031936.00081909 (2009).","journal-title":"Eur. Respir. J."},{"key":"81457_CR36","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1007\/s11357-014-9633-4","volume":"36","author":"JI Moliva","year":"2014","unstructured":"Moliva, J. I. et al. Molecular composition of the alveolar lining fluid in the aging lung. Age (Dordr ) 36, 9633. https:\/\/doi.org\/10.1007\/s11357-014-9633-4 (2014).","journal-title":"Age (Dordr )"},{"key":"81457_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJM199803053381001","volume":"338","author":"SE Valway","year":"1998","unstructured":"Valway, S. E. et al. An outbreak involving extensive transmission of a virulent strain of Mycobacerium tuberculosis. N Engl J Med 338, 633\u2013639 (1998).","journal-title":"N Engl J Med"},{"key":"81457_CR38","unstructured":"WHO. WHO operational handbook on tuberculosis. Module 4: Treatment - drug-resistant tuberculosis treatment, 2022 update. December 15, 2022 2022. Geneva: World Health Organization"},{"key":"81457_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1604544","volume":"376","author":"NS Shah","year":"2017","unstructured":"Shah, N. S. et al. Transmission of Extensively Drug-Resistant Tuberculosis in South Africa. N Engl J Med 376, 243\u2013253. https:\/\/doi.org\/10.1056\/NEJMoa1604544 (2017).","journal-title":"N Engl J Med"},{"key":"81457_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.24.2321","author":"PJ Bifani","year":"1999","unstructured":"Bifani, P. J. et al. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA https:\/\/doi.org\/10.1001\/jama.282.24.2321 (1999).","journal-title":"JAMA"},{"key":"81457_CR41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.1996.03530300036037","volume":"275","author":"PJ Bifani","year":"1996","unstructured":"Bifani, P. J. et al. Origin and interstate spread of a New York City multidrug- resistant Mycobacterium tuberculosis clone family. JAMA 275, 452\u2013457 (1996).","journal-title":"JAMA"},{"key":"81457_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz138","author":"JI Moliva","year":"2019","unstructured":"Moliva, J. I. et al. The lung mucosa environment in the elderly increases host susceptibility to mycobacterium tuberculosis infection. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiz138 (2019).","journal-title":"J. Infect. Dis."},{"key":"81457_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0156-2","author":"JM Scordo","year":"2019","unstructured":"Scordo, J. M. et al. The human lung mucosa drives differential Mycobacterium tuberculosis infection outcome in the alveolar epithelium. Mucosal Immunol. https:\/\/doi.org\/10.1038\/s41385-019-0156-2 (2019).","journal-title":"Mucosal Immunol."},{"key":"81457_CR44","first-page":"91","volume":"101","author":"GS Besra","year":"1998","unstructured":"Besra, G. S. Preparation of cell-wall fractons from mycobacteria. Methods Mol. Biol. 101, 91\u2013107 (1998).","journal-title":"Methods Mol. Biol."},{"key":"81457_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/JB.05299-11","author":"RK Dhiman","year":"2011","unstructured":"Dhiman, R. K. et al. Lipoarabinomannan localization and abundance during growth of Mycobacterium smegmatis. J. Bacteriol. https:\/\/doi.org\/10.1128\/JB.05299-11 (2011).","journal-title":"J. Bacteriol."},{"key":"81457_CR46","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4049\/jimmunol.1100823","volume":"187","author":"J Arcos","year":"2011","unstructured":"Arcos, J. et al. Human Lung Hydrolases Delineate Mycobacterium tuberculosis-Macrophage Interactions and the Capacity to Control Infection. J. Immunol. 187, 372\u2013381 (2011).","journal-title":"J. Immunol."},{"key":"81457_CR47","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1128\/IAI.68.10.5619-5627.2000","volume":"68","author":"O Olakanmi","year":"2000","unstructured":"Olakanmi, O., Britigan, B. E. & Schlesinger, L. S. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect. Immun. 68, 5619\u20135627 (2000).","journal-title":"Infect. Immun."},{"key":"81457_CR48","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1194\/jlr.M010363","volume":"52","author":"MJ Sartain","year":"2011","unstructured":"Sartain, M. J. et al. Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel \u201cMtb LipidDB\u201d. J. Lipid Res. 52, 861\u2013872 (2011).","journal-title":"J. Lipid Res."},{"key":"81457_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2011.10.013","author":"E Layre","year":"2011","unstructured":"Layre, E. et al. A comparative lipidomics platform for chemotaxonomic analysis of Mycobacterium tuberculosis. Chem. Biol. https:\/\/doi.org\/10.1016\/j.chembiol.2011.10.013 (2011).","journal-title":"Chem. Biol."},{"key":"81457_CR50","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.D063735","author":"KN Flentie","year":"2016","unstructured":"Flentie, K. N. et al. Characterization of phthiocerol and phthiodiolone dimycocerosate esters of M. tuberculosis by multiple-stage linear ion-trap MS. J. Lipid Res. https:\/\/doi.org\/10.1194\/jlr.D063735 (2016).","journal-title":"J. Lipid Res."},{"key":"81457_CR51","doi-asserted-by":"publisher","first-page":"18460","DOI":"10.1074\/jbc.272.29.18460","volume":"272","author":"GS Besra","year":"1997","unstructured":"Besra, G. S. et al. Biosynthesis of mycobacterial lipoarabinomannan. J. Biol. Chem. 272, 18460\u201318466 (1997).","journal-title":"J. Biol. Chem."},{"key":"81457_CR52","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.001042","author":"C Rens","year":"2021","unstructured":"Rens, C. et al. Roles for phthiocerol dimycocerosate lipids in Mycobacterium tuberculosis pathogenesis. Microbiology (Reading) https:\/\/doi.org\/10.1099\/mic.0.001042 (2021).","journal-title":"Microbiology (Reading)"},{"key":"81457_CR53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.041939","author":"G Huet","year":"2009","unstructured":"Huet, G. et al. A lipid profile typifies the Beijing strains of Mycobacterium tuberculosis: identification of a mutation responsible for a modification of the structures of phthiocerol dimycocerosates and phenolic glycolipids. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M109.041939 (2009).","journal-title":"J. Biol. Chem."},{"key":"81457_CR54","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.4049\/jimmunol.177.3.1805","volume":"177","author":"JB Torrelles","year":"2006","unstructured":"Torrelles, J. B., Azad, A. K. & Schlesinger, L. S. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J. Immunol. 177, 1805\u20131816 (2006).","journal-title":"J. Immunol."}],"updated-by":[{"DOI":"10.1038\/s41598-025-93606-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81457-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81457-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81457-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T21:35:57Z","timestamp":1741815357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81457-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81457"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81457-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-93606-0","URL":"https:\/\/doi.org\/10.1038\/s41598-025-93606-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"These studies were approved by our institutional BioSafety Committee (BSC) protocol number BSC-22\u2013018 and by our Human Subjects Institutional Review Board (IRB) protocol number 20170315HU (UT-Health San Antonio) as described in our Materials and Methods.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Biosafety and ethical approval"}}],"article-number":"30840"}}